Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,21702,785,1.33 [1.05-1.70],0.0204404968674051
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21701,127,3.29 [1.94-5.58],9.817224885482724e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23073,134,0.95 [0.53-1.71],0.8650100377697743
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17199,439,2.23 [1.62-3.06],9.392808640617404e-07
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,23019,80,1.01 [0.47-2.14],0.989457895934065
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22389,71,3.72 [1.89-7.32],0.000147359831624
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23903,79,1.07 [0.50-2.26],0.8695890439696371
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23924,53,0.51 [0.20-1.29],0.1557418550986545
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21913,40,6.32 [2.95-13.57],2.2212131721856323e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23466,96,2.79 [1.51-5.18],0.0011129088794547
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23431,61,4.33 [2.17-8.64],3.136965169058007e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23961,57,1.36 [0.57-3.26],0.4936538966506295
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23925,90,1.97 [1.01-3.86],0.0476138878431205
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23917,82,1.87 [0.92-3.79],0.0841515430414308
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Mycoses,23764,45,1.95 [0.78-4.91],0.1541999959956623
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23204,334,1.35 [0.94-1.94],0.1095055166622464
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22991,121,1.41 [0.77-2.59],0.2638691564473757
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23088,218,1.56 [1.00-2.44],0.0488693798487997
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",20763,28,0.42 [0.12-1.49],0.1793859709630753
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",20778,43,0.82 [0.29-2.35],0.7161967605760334
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",20848,113,nan [nan-nan],
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",20853,118,0.85 [0.45-1.60],0.6141035431926145
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",11660,258,9.12 [6.43-12.93],2.9156878096734625e-35
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9354,21,2.17 [0.56-8.35],0.2603861532396598
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",20778,43,0.74 [0.26-2.07],0.5594872388555392
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22139,703,1.36 [1.06-1.76],0.0175643871519123
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23062,182,1.16 [0.71-1.90],0.5494013170125339
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23597,73,1.49 [0.69-3.20],0.3055491384621994
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24029,69,0.62 [0.27-1.39],0.2452739150221459
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Rectum,23827,41,2.25 [0.86-5.91],0.1002362964602107
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24032,32,1.13 [0.35-3.66],0.8434526623611799
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Stomach,24067,25,0.93 [0.24-3.57],0.9141181483579756
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm,23800,261,0.79 [0.52-1.19],0.2566744249310898
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,24008,104,0.61 [0.31-1.18],0.1399955956539477
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,24012,80,0.91 [0.43-1.93],0.8099088920671318
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23982,40,0.29 [0.10-0.82],0.0200898243704317
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Haemangioma, any site",23984,40,0.29 [0.10-0.82],0.0200895011718846
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Melanocytic naevi,23888,208,0.40 [0.25-0.65],0.0001562578150699
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,24033,95,0.45 [0.22-0.90],0.0232891212147002
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Other benign neoplasms of skin,23947,162,1.42 [0.85-2.38],0.1833814433418271
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm of breast,13272,81,1.31 [0.63-2.73],0.4720252798130219
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Leiomyoma of uterus,12968,608,0.78 [0.59-1.03],0.0786262529893371
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23201,169,1.17 [0.70-1.95],0.5565048898012104
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23102,303,1.61 [1.10-2.35],0.0142536766780071
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23102,303,1.61 [1.10-2.35],0.0142536766780071
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22025,307,2.47 [1.72-3.56],1.0632496885927205e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23641,68,1.72 [0.78-3.79],0.1757195661082098
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23848,88,2.78 [1.46-5.29],0.0018335750879649
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21093,611,2.25 [1.72-2.94],2.5269907738852182e-09
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22959,376,0.74 [0.52-1.05],0.0886882636399339
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,22484,92,0.61 [0.30-1.23],0.1668282677516854
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23392,51,1.37 [0.54-3.46],0.5114858252266206
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22472,80,0.60 [0.28-1.29],0.1921936856475651
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,22670,278,1.21 [0.81-1.82],0.3554699167435069
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22663,271,1.20 [0.79-1.81],0.3854789679537057
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22365,157,1.66 [0.93-2.97],0.0840526568030541
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22369,155,1.77 [0.99-3.16],0.0529103772154958
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,20956,474,2.05 [1.51-2.78],4.561666415203966e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20545,63,1.41 [0.61-3.25],0.4247673947212308
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,20919,437,2.04 [1.48-2.80],1.0878597003054204e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20523,41,6.19 [2.98-12.84],9.824902635047237e-07
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20544,62,6.62 [3.63-12.07],7.272939164538701e-10
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Any mental disorder,20843,659,1.18 [0.91-1.55],0.2177186105647321
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20437,253,1.42 [0.93-2.18],0.1048357024325306
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23689,190,1.53 [0.95-2.47],0.0786280604834571
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23744,137,1.46 [0.83-2.55],0.1859120180956147
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,22339,68,1.26 [0.57-2.81],0.5675670600826856
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23970,68,1.31 [0.59-2.91],0.5001863382603747
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",20252,68,1.24 [0.55-2.78],0.599333646461718
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Alcohol dependence,22350,79,1.05 [0.49-2.22],0.9049281852911876
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Smoking dependency,22313,61,1.70 [0.75-3.87],0.2074707137288863
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20252,68,1.31 [0.60-2.88],0.5001412933725797
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20513,329,1.28 [0.88-1.85],0.1943681872513549
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Depression,22557,285,1.24 [0.84-1.85],0.2831507102524137
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Depression or dysthymia,20389,249,1.14 [0.74-1.75],0.5440491964340114
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20306,122,0.91 [0.49-1.68],0.7572198259707295
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Other anxiety disorders,22764,55,0.78 [0.31-1.95],0.5981547230535866
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Neurological diseases,21412,1273,0.91 [0.75-1.10],0.3328132608742531
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19940,151,0.47 [0.27-0.83],0.0090862121645336
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23878,123,0.46 [0.25-0.86],0.0138078346981433
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22914,427,0.92 [0.66-1.28],0.6329553722429612
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Epilepsy,22630,143,0.58 [0.33-1.01],0.0554635064210189
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Migraine,22573,86,0.79 [0.38-1.64],0.5296857318708929
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23745,77,0.79 [0.37-1.70],0.5461098146083461
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23644,37,1.91 [0.67-5.41],0.2257382049545476
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other sleep disorders,22639,152,1.43 [0.83-2.45],0.1982500443062423
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Sleep apnoea,23531,116,1.32 [0.71-2.46],0.3860813939024784
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23075,535,0.95 [0.70-1.27],0.709512651862527
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22664,124,1.77 [0.99-3.16],0.0544488530057914
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22828,288,0.83 [0.56-1.24],0.3747800805734473
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23877,76,0.95 [0.44-2.05],0.9006896826007776
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Hemiplegia,23850,49,0.85 [0.33-2.21],0.745963494402244
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other neurological diseases,23692,105,1.80 [0.96-3.38],0.0653251668049714
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23657,272,0.81 [0.54-1.22],0.3045576191382577
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23530,145,0.86 [0.49-1.51],0.6002721093717306
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23463,78,0.80 [0.37-1.72],0.5692434696062009
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23471,86,0.84 [0.41-1.74],0.6461493623016197
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23428,43,0.74 [0.26-2.06],0.5642258409276467
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22556,52,0.61 [0.24-1.53],0.2900671785135561
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22666,162,1.26 [0.75-2.12],0.3832036211796072
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23530,106,1.29 [0.68-2.46],0.4322624955651228
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23848,18,0.93 [0.19-4.47],0.9230943755082294
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1527,18,0.76 [0.17-3.45],0.7211478857959246
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",22339,18,0.93 [0.19-4.54],0.9319751954779838
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23739,43,0.47 [0.17-1.30],0.1457834431961197
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23719,23,0.39 [0.10-1.52],0.1731128132608668
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23648,81,0.42 [0.20-0.88],0.0220356252309266
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23706,88,0.54 [0.26-1.11],0.0951775270082602
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23952,112,1.10 [0.59-2.06],0.7682447031361617
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,23599,83,2.20 [1.11-4.36],0.0241589711903449
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18784,1714,1.87 [1.57-2.23],2.604254198205377e-12
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23797,36,2.38 [0.86-6.60],0.0957088266434642
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19703,1153,1.88 [1.53-2.32],2.566487558969142e-09
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Hypertension,19720,1170,1.98 [1.62-2.44],6.639620075074238e-11
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18583,33,,
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22771,496,1.91 [1.42-2.57],1.6597518332438735e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Angina pectoris,22575,300,1.60 [1.09-2.34],0.0161140191526677
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23444,117,0.89 [0.48-1.65],0.7110443108161839
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23551,224,1.38 [0.89-2.15],0.1505698541193982
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23970,50,1.68 [0.68-4.14],0.2621409990040577
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22415,140,2.15 [1.25-3.70],0.0054924581598793
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22638,372,2.30 [1.65-3.20],8.961967707463944e-07
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23615,73,1.54 [0.72-3.29],0.2680334795142997
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23621,154,1.67 [0.99-2.81],0.0544429635814166
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23602,60,3.27 [1.58-6.80],0.0014736563176795
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23603,61,3.41 [1.66-6.99],0.0008000083835712
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18607,57,3.46 [1.66-7.23],0.0009390667185405
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21776,40,1.57 [0.55-4.48],0.4032479580988365
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Conduction disorders,21800,64,1.78 [0.79-4.03],0.1640763004095508
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16378,79,1.00 [0.46-2.16],0.9987611734149276
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16467,168,2.42 [1.48-3.94],0.0003909081409419
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,21773,37,3.77 [1.55-9.21],0.0035288596955241
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21788,52,1.04 [0.41-2.66],0.9327156003842804
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23620,108,4.12 [2.42-7.02],1.9183314917538305e-07
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23595,95,1.30 [0.66-2.56],0.4417800514794079
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23626,70,1.27 [0.58-2.78],0.5514888504525606
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23668,61,1.25 [0.54-2.91],0.5997067463607726
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23407,44,2.39 [0.92-6.20],0.0734642766606748
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23438,75,1.03 [0.48-2.25],0.9343704050186536
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),23014,101,2.20 [1.18-4.12],0.0135866385342995
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22997,84,2.50 [1.28-4.88],0.0075898227097181
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23924,81,2.56 [1.31-5.01],0.0060712111684887
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Varicose veins,23289,376,0.75 [0.53-1.07],0.1093840457308496
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Hypotension,23430,44,1.04 [0.38-2.87],0.9407097565672612
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,20345,1696,1.18 [0.99-1.40],0.0618328093206255
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23867,119,1.32 [0.72-2.41],0.3682129839669545
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23019,164,1.75 [1.05-2.90],0.0319633731657399
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22994,139,1.83 [1.05-3.17],0.0316427954430188
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23517,193,1.82 [1.14-2.90],0.0116357140165965
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23516,192,1.81 [1.14-2.89],0.0127157653846816
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23289,574,1.24 [0.94-1.64],0.1328245122101357
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22804,89,0.91 [0.45-1.86],0.7987653612251058
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Nasal polyp,22810,95,1.99 [1.03-3.82],0.0395941903583746
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23085,370,1.14 [0.80-1.62],0.4615362708115548
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22911,196,1.33 [0.83-2.14],0.2319618627326015
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13801,43,2.11 [0.82-5.44],0.1220041481933708
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22010,773,0.94 [0.73-1.20],0.6060569320541931
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Early onset COPD,23440,92,1.40 [0.70-2.80],0.3438905575744322
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23440,92,1.40 [0.70-2.80],0.3438905575744322
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",23440,92,1.40 [0.70-2.80],0.3438905575744322
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",22526,699,0.80 [0.62-1.04],0.1006418423304696
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Asthma,18369,699,0.83 [0.63-1.08],0.1604543549439571
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18238,699,0.83 [0.64-1.09],0.177328534202777
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18354,684,0.83 [0.63-1.08],0.169931690701993
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23897,57,4.20 [2.07-8.54],7.144012142939117e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22895,43,1.91 [0.72-5.08],0.1922120065060767
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23955,43,1.90 [0.73-4.98],0.1913662039004616
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22889,37,2.01 [0.71-5.71],0.1915940738802344
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pleural effusion,22887,68,1.93 [0.89-4.18],0.0961155925037747
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,22974,155,2.21 [1.33-3.66],0.0021143283765159
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23325,70,3.48 [1.77-6.85],0.00029297222016
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,17104,4496,1.00 [0.89-1.13],0.9445294227568936
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23542,427,1.07 [0.77-1.48],0.6994450190822812
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,24004,116,0.79 [0.42-1.49],0.4627925678019451
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Impacted teeth,24009,106,0.77 [0.40-1.50],0.4499214907605436
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Dental caries,23217,102,1.28 [0.67-2.45],0.4507862180653107
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23213,98,1.05 [0.53-2.06],0.8917432826073577
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23991,131,0.76 [0.42-1.38],0.3710723495859211
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23194,79,0.95 [0.45-2.02],0.893335134993318
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22979,55,0.59 [0.24-1.46],0.2549083533719708
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23960,41,0.41 [0.14-1.16],0.0930430430968217
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19345,185,1.39 [0.85-2.27],0.1843039479875164
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20698,1538,0.99 [0.83-1.18],0.9079893270544744
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Oesophagitis,19394,234,1.41 [0.92-2.18],0.1177492628481267
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19654,494,0.99 [0.72-1.34],0.9259982096457716
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19220,60,1.10 [0.46-2.61],0.8318340173830243
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19286,126,1.77 [0.99-3.17],0.0538382308483972
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19186,26,0.98 [0.26-3.71],0.9762595055800608
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastric ulcer,19253,93,1.42 [0.71-2.81],0.3187003212953158
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,19254,94,1.48 [0.75-2.91],0.2598528534110066
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23977,66,1.03 [0.45-2.34],0.9479129936267798
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Chronic gastritis,19256,96,0.54 [0.27-1.07],0.0778842051085992
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19724,564,1.12 [0.84-1.50],0.4251500159797675
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of appendix,23907,140,0.92 [0.52-1.64],0.78872862077494
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,19495,335,0.74 [0.51-1.08],0.120716731851889
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19259,99,1.35 [0.69-2.64],0.3825675246622841
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23896,168,0.83 [0.49-1.40],0.492407460796853
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute appendicitis,23878,111,1.15 [0.61-2.18],0.6672716814575483
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Hernia,21697,1045,1.23 [1.00-1.52],0.052162547621653
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Inguinal hernia,20999,347,1.56 [1.09-2.22],0.0145954594262456
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Umbilical hernia,20753,101,1.55 [0.81-2.96],0.1880418566025384
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Ventral hernia,20733,81,1.42 [0.69-2.94],0.3437017082099357
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,21193,541,1.12 [0.83-1.50],0.4568197367299511
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23307,655,1.37 [1.05-1.78],0.0182068445024081
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,19809,1461,0.94 [0.78-1.13],0.477632410812817
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23777,63,3.14 [1.50-6.57],0.0024318450742264
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23992,89,2.54 [1.33-4.86],0.0049747098219018
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Crohn disease,22741,89,2.59 [1.35-4.97],0.0042630889917242
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22721,69,3.96 [2.03-7.71],5.295470022434211e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23946,113,1.55 [0.84-2.86],0.1631211488568127
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,22765,113,1.58 [0.85-2.93],0.1478255848843278
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22748,96,1.51 [0.77-2.95],0.2314813226321863
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23180,528,1.09 [0.81-1.46],0.5712083933005927
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23176,524,1.09 [0.81-1.46],0.5698735425964252
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18407,59,1.49 [0.63-3.54],0.3635745242959717
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Intestinal stricture,23764,59,1.45 [0.61-3.41],0.3965331387938976
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18389,41,1.95 [0.71-5.35],0.1927207381086592
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18620,272,0.99 [0.65-1.49],0.9482097023310432
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18497,149,0.80 [0.45-1.40],0.4257366736081525
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18566,218,1.05 [0.66-1.67],0.8285865975877669
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Constipation,23057,193,1.15 [0.71-1.86],0.5668178402792928
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23683,72,0.93 [0.42-2.06],0.8552063607321546
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18505,157,0.87 [0.50-1.50],0.6151790727855295
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18429,81,0.92 [0.43-1.96],0.8190257903426879
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19043,695,0.84 [0.64-1.09],0.1844188367407171
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,18506,158,1.17 [0.69-2.00],0.5605285250224346
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23672,61,0.87 [0.36-2.07],0.7462013995898541
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of liver,23424,105,1.79 [0.97-3.33],0.0643511730577275
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of liver,23379,60,2.09 [0.94-4.65],0.0713875686183593
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22959,451,0.86 [0.63-1.19],0.3774130707441839
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Cholelithiasis,22868,360,0.86 [0.60-1.23],0.3955845853060429
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Cholecystitis,22575,67,0.81 [0.35-1.85],0.6113257928792888
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22545,37,0.88 [0.29-2.65],0.817431180982765
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,22557,49,1.91 [0.78-4.68],0.1581123879039017
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23909,49,1.92 [0.78-4.71],0.155511363151182
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22975,246,0.91 [0.59-1.39],0.6526904219167556
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22786,57,0.32 [0.13-0.76],0.0106323986073469
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Coeliac disease,22776,47,0.34 [0.13-0.90],0.0299518190861056
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22767,38,1.41 [0.49-4.12],0.5252207535745201
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22884,155,1.11 [0.65-1.90],0.7045309642635712
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,GI-bleeding,22879,150,1.10 [0.63-1.89],0.7437583012099609
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21827,1291,0.97 [0.80-1.18],0.7929934783808416
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23733,91,1.37 [0.69-2.73],0.3720216146218186
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23701,404,1.38 [0.99-1.92],0.0553168922525052
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23098,454,0.80 [0.58-1.11],0.1799267792511945
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23378,355,0.91 [0.63-1.31],0.6124853529048948
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23116,93,0.56 [0.27-1.13],0.103432219153366
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23225,202,1.14 [0.71-1.83],0.5939781292287643
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23842,73,1.68 [0.79-3.55],0.1776253538586093
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23830,61,1.60 [0.70-3.66],0.2632259307379123
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23814,45,2.70 [1.11-6.56],0.0279164174440594
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23927,27,0.94 [0.26-3.44],0.9309715492028764
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23924,24,0.95 [0.24-3.76],0.9380424101257444
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23355,58,1.98 [0.86-4.57],0.1077461828452476
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23602,305,1.49 [1.02-2.18],0.0376243300374262
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22706,62,0.65 [0.27-1.55],0.3298842906872465
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22729,85,0.70 [0.34-1.47],0.3456715621827624
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22717,73,0.65 [0.29-1.44],0.2857173099071897
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22819,175,0.94 [0.56-1.56],0.7989913262919924
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22798,154,0.80 [0.46-1.38],0.4214056740322528
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18614,3056,0.99 [0.86-1.13],0.8478143715384661
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20006,1635,1.02 [0.86-1.22],0.8050472621889802
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21927,951,0.91 [0.73-1.14],0.4124743960716184
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18483,112,0.71 [0.37-1.36],0.3078745076447099
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18677,306,1.05 [0.71-1.55],0.8085419818838332
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23769,107,0.67 [0.35-1.28],0.2218192391442686
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23781,95,0.73 [0.37-1.47],0.381073027005761
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,18946,575,1.01 [0.76-1.35],0.93051025386913
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",21200,575,0.98 [0.74-1.30],0.8960874650923876
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18410,39,4.26 [1.84-9.83],0.0006887760117959
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23732,38,4.44 [1.91-10.36],0.0005534091852299
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18503,132,0.76 [0.42-1.37],0.3551826667647256
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18393,22,0.58 [0.14-2.49],0.4675333644173692
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18481,110,0.72 [0.38-1.38],0.3264413592790163
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23962,55,1.23 [0.50-2.99],0.6516951851969776
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18661,290,1.31 [0.88-1.94],0.1804096944296799
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18562,191,0.75 [0.45-1.23],0.2563914481658637
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,19454,1083,1.10 [0.89-1.36],0.3847781267764293
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18409,38,1.74 [0.61-4.99],0.2999930075924036
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18525,154,0.60 [0.34-1.04],0.0700183216420622
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18396,25,0.46 [0.12-1.82],0.2700521970811286
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18397,26,0.47 [0.12-1.82],0.2767762727198776
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18817,446,1.31 [0.95-1.81],0.0965802049481554
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18743,372,1.30 [0.92-1.85],0.1416769643724855
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18992,246,1.17 [0.76-1.80],0.4665044915674584
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23708,142,0.86 [0.49-1.51],0.5921125424094023
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23603,37,1.52 [0.52-4.43],0.4424724781619006
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21476,45,1.00 [0.37-2.72],0.9985662654413948
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21626,195,1.36 [0.85-2.19],0.2038530038425831
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22229,798,1.02 [0.80-1.30],0.901600712299241
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21552,121,1.13 [0.62-2.07],0.6935034988994013
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21480,49,1.06 [0.41-2.77],0.898663910354188
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22103,672,0.95 [0.73-1.24],0.7218661400430456
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21480,49,1.94 [0.78-4.82],0.154626459898768
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21663,232,1.17 [0.76-1.82],0.4731331395637769
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21534,103,1.34 [0.69-2.57],0.3856719570947142
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21489,58,0.61 [0.25-1.49],0.278733090871005
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21554,123,1.15 [0.63-2.09],0.6569456508162739
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21490,59,0.78 [0.32-1.87],0.5727860570896839
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21717,286,0.89 [0.59-1.33],0.5583775531399422
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21218,242,0.94 [0.61-1.45],0.7788194211468076
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,21025,49,1.70 [0.67-4.28],0.2622348485582643
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,21017,41,0.64 [0.22-1.84],0.4114237958873034
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,21076,100,0.69 [0.35-1.36],0.2847462222820492
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",21028,52,0.69 [0.27-1.79],0.45158674686418
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,21029,53,0.50 [0.20-1.27],0.1455777215733421
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],21015,39,0.79 [0.27-2.37],0.6785264838622569
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21162,186,1.05 [0.64-1.72],0.8486821586861308
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,21023,47,1.49 [0.58-3.85],0.4111496655943701
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21019,43,1.52 [0.57-4.08],0.4007359977976504
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21068,92,0.85 [0.42-1.73],0.6589666849162077
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,21039,63,0.91 [0.39-2.12],0.8234077032787619
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21359,383,1.03 [0.73-1.45],0.8668996395781197
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21109,133,1.24 [0.70-2.20],0.469669489481903
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21173,197,0.96 [0.59-1.55],0.8658301184601829
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22841,91,1.03 [0.51-2.07],0.9339329435286844
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23043,293,1.19 [0.80-1.75],0.3936051725161793
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22799,49,1.85 [0.74-4.65],0.1882099585262564
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22806,56,0.77 [0.31-1.92],0.5791224447882619
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22850,100,1.03 [0.53-2.02],0.9302359415183736
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20381,3794,0.76 [0.67-0.85],7.632320798227762e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,9766,347,1.27 [0.87-1.84],0.2194654773985799
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22759,164,,
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22642,47,3.52 [1.49-8.34],0.0042166010265052
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22898,32,,
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22898,32,,
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22906,40,,
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23746,201,1.45 [0.91-2.30],0.1156034948005069
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23809,48,9.89 [5.42-18.05],8.3740463433365e-14
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23686,141,1.77 [1.03-3.04],0.0371241114198026
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23627,82,1.13 [0.54-2.35],0.7510390235677891
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22755,767,0.82 [0.64-1.05],0.1156006760925856
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Cystitis,22059,71,0.74 [0.33-1.66],0.4658679420674058
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,22045,57,1.64 [0.68-3.92],0.2688240876365897
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22143,155,1.48 [0.87-2.51],0.1505107824698054
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,22068,80,0.87 [0.41-1.87],0.7299049759894525
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22528,540,0.78 [0.58-1.05],0.0966679115542206
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9478,59,0.87 [0.35-2.16],0.7710623014477038
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9452,33,2.19 [0.72-6.67],0.1691381005267325
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,9454,35,2.73 [0.96-7.75],0.058778554528954
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9491,72,1.05 [0.46-2.41],0.9058755081004366
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9475,56,0.78 [0.30-1.99],0.5993074395062132
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9501,82,2.32 [1.13-4.78],0.0222441388892591
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,13149,218,2.11 [1.37-3.24],0.0006710266735622
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,12997,66,1.45 [0.65-3.24],0.3644291850155624
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,13004,73,3.05 [1.52-6.09],0.0016134507956063
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,12978,47,1.95 [0.78-4.92],0.1556336585507031
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,13116,340,0.86 [0.59-1.25],0.43801203859725
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,12847,71,0.63 [0.28-1.40],0.2561692942949547
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,12946,170,0.88 [0.52-1.48],0.631013399054668
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,12100,2392,0.88 [0.76-1.03],0.1213953054324738
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,9956,248,1.35 [0.87-2.07],0.1786486536278515
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,9785,77,1.00 [0.46-2.18],0.9905543320793972
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9807,99,1.35 [0.68-2.66],0.389242679347053
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9973,265,0.54 [0.36-0.83],0.0051427516297919
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9975,267,0.62 [0.41-0.95],0.0296252573627411
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10126,418,0.73 [0.52-1.02],0.0677999445980142
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9856,148,0.53 [0.30-0.94],0.0285761682243435
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9897,189,1.10 [0.67-1.82],0.6965251423751926
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,9781,73,0.76 [0.34-1.70],0.5059504335828784
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,9837,129,1.04 [0.57-1.90],0.8998961913815974
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",13277,175,1.07 [0.64-1.77],0.8068551868611926
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,13286,168,1.07 [0.64-1.79],0.8026174495393731
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,13302,94,1.14 [0.57-2.27],0.7137274239907357
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",13294,102,1.13 [0.58-2.19],0.7184027400223281
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9768,60,0.57 [0.23-1.38],0.2097688629030782
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9762,54,1.08 [0.43-2.73],0.8704006431428828
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9770,62,0.37 [0.16-0.89],0.02625428150154
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,13216,319,0.96 [0.66-1.41],0.8544172953992731
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",10696,988,0.90 [0.71-1.13],0.3439179678805467
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,10391,683,0.86 [0.65-1.13],0.2714689722730088
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",13289,138,0.84 [0.47-1.50],0.555852228482768
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,10012,304,1.25 [0.85-1.84],0.2650153972437894
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9937,229,1.00 [0.63-1.57],0.9858791651347324
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9930,222,0.80 [0.50-1.27],0.3417656404792901
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Female infertility,9791,83,0.93 [0.44-2.00],0.8596388252379965
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",9784,76,0.88 [0.39-1.94],0.7443450288260663
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,13294,720,0.77 [0.58-1.02],0.0702536626924746
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,13301,987,0.71 [0.55-0.91],0.0065650964481732
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,13295,379,1.30 [0.92-1.85],0.1420888582971881
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,13023,107,0.89 [0.46-1.73],0.7382641562797594
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,13063,147,1.50 [0.87-2.58],0.14431910341393
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,13053,137,1.44 [0.82-2.50],0.2009241580026314
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",13311,142,0.54 [0.30-0.97],0.0403089057155167
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,13313,139,0.53 [0.29-0.97],0.039328250237857
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,13311,352,0.72 [0.49-1.06],0.0949991810592626
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,13063,104,0.62 [0.31-1.22],0.1670875753386473
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,13155,196,0.60 [0.36-1.00],0.0483755572411385
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,12697,123,0.89 [0.47-1.67],0.7148888261219479
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,12740,166,0.69 [0.40-1.18],0.176510501689543
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,12775,201,0.74 [0.45-1.21],0.2258456521692139
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,12696,122,0.96 [0.52-1.79],0.8960317060819637
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,12686,112,0.67 [0.35-1.29],0.2295142888691944
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,12700,126,0.99 [0.53-1.83],0.9735371892315344
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,12498,184,0.77 [0.46-1.32],0.3457374801571011
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],12679,365,0.61 [0.41-0.89],0.0105708321067608
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,12862,548,0.81 [0.59-1.12],0.207117719472638
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",13316,144,0.59 [0.33-1.05],0.0739068814592476
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,12120,110,0.44 [0.23-0.86],0.0166615594105078
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",12398,84,0.44 [0.20-0.94],0.0332736903635919
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,13321,279,0.69 [0.45-1.05],0.0839183902648703
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,13258,216,0.61 [0.38-0.99],0.0433916068121451
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",13310,214,1.36 [0.85-2.17],0.1976458117160459
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",13300,204,1.40 [0.87-2.26],0.1662562856997064
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23848,31,0.90 [0.27-2.98],0.8618506490651175
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22624,440,1.05 [0.76-1.45],0.7590930303245769
